MyAverix Finance
TWO · Healthcare
Easywell Biomedicals Inc. (1799)
Drug Manufacturers - Specialty & Generic
Easywell Biomedicals Inc. (1799) is listed on TWO in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 1799
Easywell Biomedicals Inc. (1799) — FAQ
What is 1799's P/E ratio?
The price-to-earnings (P/E) ratio for Easywell Biomedicals Inc. (1799) is 18.00 (data as of 2026-05-23).
Does Easywell Biomedicals Inc. pay a dividend?
Dividend yield is not available in the current snapshot for Easywell Biomedicals Inc. (1799). Check the MyAverix Finance app for the latest dividend data.
What sector is Easywell Biomedicals Inc. in?
Easywell Biomedicals Inc. (1799) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 1799 listed on?
1799 is listed on TWO.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.